Skip to main content

On-demand webinar: Real-life data on switching medication 

While the increasing number of highly effective immunotherapies for multiple sclerosis has improved disease control, no disease modifying therapy (DMT) is entirely effective in halting disease activity. Switching DMT should therefore be considered in cases of breakthrough disease or an inadequate response to therapy, intolerability or specific side effects, adverse events, family planning, compliance issues, psychosocial reasons, and economic reasons. The aging MS population also raises the need for de-escalation of DMT, emphasizing the importance of the risks and benefits of such a switch which should be considered on a case-by-case basis. Real-life data can contribute with evidence on predictors of treatment response, guide the selection of the most appropriate DMT for individual patients, and inform treatment decisions when switching DMTs.



Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved in pharmacoepidemiological studies investigating the effectiveness and long-term safety of disease modifying therapies.



  • Directors

  • Author(s)

    Prof Melinda Magyari
  • Country

  • Release Date

    April 25, 2023
  • Views


Educational slide decks
endorsed by experts

Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated.
The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.

Consensus publications

Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.

Regional and national educational events

Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.

Web-based educational tools and resources

Webinars can complement the educational events.

Medical education (ME) programs

The educational slide decks, events and webinars can be important building blocks of accredited educational programs.


Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.

Terms and Conditions

All the Terms and Conditions of the ParadigMS Foundation Website can be downloaded here.